These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11555638)

  • 1. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
    Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
    J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop.
    Jankova L; Harrop SJ; Saunders DN; Andrews JL; Bertram KC; Gould AR; Baker MS; Curmi PM
    J Biol Chem; 2001 Nov; 276(46):43374-82. PubMed ID: 11546761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function.
    Harrop SJ; Jankova L; Coles M; Jardine D; Whittaker JS; Gould AR; Meister A; King GC; Mabbutt BC; Curmi PM
    Structure; 1999 Jan; 7(1):43-54. PubMed ID: 10368272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M; Busse MN; Andreasen PA
    Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.
    Ko CW; Wei Z; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Zhou A; Ying L
    Mol Biosyst; 2009 Sep; 5(9):1025-31. PubMed ID: 19668868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
    Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.
    Lawrence DA; Olson ST; Muhammad S; Day DE; Kvassman JO; Ginsburg D; Shore JD
    J Biol Chem; 2000 Feb; 275(8):5839-44. PubMed ID: 10681574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
    Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
    Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2.
    Saunders DN; Buttigieg KM; Gould A; McPhun V; Baker MS
    J Biol Chem; 1998 May; 273(18):10965-71. PubMed ID: 9556575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.
    Na YR; Im H
    Protein Sci; 2005 Jan; 14(1):55-63. PubMed ID: 15576554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
    Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.
    Hägglöf P; Bergström F; Wilczynska M; Johansson LB; Ny T
    J Mol Biol; 2004 Jan; 335(3):823-32. PubMed ID: 14687577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
    Ibarra CA; Blouse GE; Christian TD; Shore JD
    J Biol Chem; 2004 Jan; 279(5):3643-50. PubMed ID: 14594804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
    Kirkegaard T; Jensen S; Schousboe SL; Petersen HH; Egelund R; Andreasen PA; Rodenburg KW
    Eur J Biochem; 1999 Jul; 263(2):577-86. PubMed ID: 10406969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands.
    Li SH; Gorlatova NV; Lawrence DA; Schwartz BS
    J Biol Chem; 2008 Jun; 283(26):18147-57. PubMed ID: 18436534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
    Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
    Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.